• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Saudi Arabia·Healthcare·4005.SR
Share

National Medical Care Company Stocks

SAR 115.8Last Updated 27.07.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

SAR 1.37B

SAR 115.8
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

National Medical Care Company is dedicated to the comprehensive establishment, ownership, operation, and maintenance of healthcare facilities across the Kingdom of Saudi Arabia. Its substantial portfolio includes the 325-bed Riyadh Care Hospital, the 459-bed National Hospital, the Family Health Care Center, and the Care Company for Pharmaceutical and Medical Distribution. In addition to these institutional services, the company also provides home healthcare. Founded in 2003, it is headquartered in Riyadh, Saudi Arabia.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 4005.SR is 129 and suggests 12.3% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 19:40

"A Pure Expression of Power": How Christopher Nolan's "Odyssey" Will Change IMAX

28.07.2026 19:12

The Nasdaq 100 has entered a correction phase. The "Wall Street fear" index jumped

28.07.2026 18:30

Southern Japan has been hit by the strongest earthquake in 10 years. TSMC and Sony have factories there.

28.07.2026 17:57

The dollar index has stabilized near a four-week high ahead of the Fed's decision

28.07.2026 17:30

Mercedes has lowered its forecast due to a decline in demand for luxury models. Why did its stock price jump?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026